BioSpace
FDA uncertainty persists as search for Prasad successor at CBER drags on
The FDA is reportedly down to a handful of final candidates to lead CBER, with a potential selection expected in the coming ...
FDA names new director for vaccines, biologics unit
The Food and Drug Administration (FDA) has named Katherine Szarama to be the acting director of the unit in charge of ...
STAT
Katherine Szarama named acting director of FDA’s vaccines and biologics center
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
BioSpace
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
The FDA turned away Ebvallo in January, taking issue with the design of the registrational trial. In a recent meeting, however, the agency agreed that the study could in fact support the cell ...
Opinion
Goshen NewsOpinion
ANOTHER OPINION: Changes at FDA after Vinay Prasad's departure
Vinay Prasad on Thursday served his final day at the Food and Drug Administration. Now the bad news: Commissioner Marty Makary has tapped Dr. Prasad’s deputy, Katherine Szarama, ...
AOL
FDA vaccines chief Dr. Vinay Prasad to leave regulator in April
The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the end of April. FDA commissioner Dr. Marty Makary posted ...
India Today on MSN
What forced Vinay Prasad to exit top job at US FDA in just 3 months
Indian-origin scientist Vinay Prasad resigned as the FDA's vaccine and gene therapy chief in just three months after backlash ...
Wall Street Journal
Vinay Prasad Is Leaving the FDA / Anthropic Sues the Pentagon
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Speaker 1: From the opinion pages of the Wall Street Journal, this is Potomac ...
KSL
FDA vaccines chief Vinay Prasad to leave regulator in April
WHITE OAK, Md. — The controversial head of the Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the end of April. FDA Commissioner Dr. Marty ...